MetaCap

Azitra (AZTR) vs Soligenix (SNGX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Azitra is the larger company by market cap ($8.0 million vs $7.5 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

AZTR versus SNGX key metrics
MetricAZTRSNGX
Share price$0.132$0.3466
Market cap$8.00M$7.54M
1-day change0.00%-1.95%
EPS (TTM)$-0.28$-0.79
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.09$1.97
52-week low$0.10$0.28
Distance from 52-week high-87.89%-82.41%
Average volume1.70M253.75K
Shares outstanding60.60M21.77M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

AZTR vs SNGX FAQ

Which is bigger, Azitra or Soligenix?

Azitra (AZTR) is larger, with a market capitalization of $8.00M compared with $7.54M for Soligenix (SNGX).

Are Azitra and Soligenix in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons